Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : email@example.com
WVT078 is a bispecific antibody that targets the B-cell maturation antigen (BCMA; TNFRSF17) expressed on tumor cells and the T-cell antigen CD3, potentially resulting in activation of cytotoxic T-lymphocytes (CTLs) and killing of BCMA-expressing tumor cells (NCI Thesaurus).
|DrugClasses||CD3 Antibody 78 TNFRSF17 Antibody 14|
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|